Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that ...

Veeva Systems shines with 14% revenue growth, CRM adoption momentum, and Data Cloud innovations. Read why VEEV stock is a ...

Veeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

In a report released today, Saket Kalia from Barclays maintained a Buy rating on Veeva Systems (VEEV – Research Report), with a price target of ...

1 Day VEEV 0.39% DJIA 0.08% S&P 500 0.08% Technology 0.49% ...

Veeva Systems (VEEV) could be a solid choice for investors ... This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock ...

1 Day VEEV -1.38% DJIA -1.69% S&P 500 -1.97% Technology -2.73% ...

Veeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Veeva (VEEV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.